COVID Vaccines

UK’s COVID Vaccination Plan : The When, How, and Where To Get the Vaccine

Britain’s NHS has begun the biggest mass vaccination campaign in its history to protect people against Covid-19 and as the vaccination drives proceeds further BBC analysed how candidates are chosen, informing when people are eligible for the vaccine. 

Here’s a report from that analysis. 

The Approved Vaccines

So far, three vaccines have been approved for use in the UK.

More than 1.5 million people in the UK have now been vaccinated – the large majority with the Pfizer-BioNTech vaccine which was...

https://mfame.guru/uks-covid-vaccination-plan-the-when-how-and-where-to-get-the-vaccine/

US President’s COVID Antibody Treatment Receives FDA Emergency Approval

According to a BBC report, the drug, developed by Regeneron, will be allowed for use in people who have tested positive for the virus and are at risk of severe illness.

Studies suggest the therapy is effective when administered early after diagnosis, the company says.

Emergency authorisation by the Food and Drug Administration (FDA) allows use of a treatment while studies are carried out to determine safety and effectiveness.



A similar drug made by Eli Lilly, another US pharmaceutical firm, was...

https://mfame.guru/us-presidents-covid-antibody-treatment-receives-fda-emergency-approval/

New Nasal Vaccines Touted To Be ‘Game Changer’ in COVID Testing

  • Kiran Mazumdar-Shaw has said that intra-nasal vaccines will be far easier to deliver than intra muscular injections.
  • Inhaled vaccine makers are counting on some of the unique features of the lungs, nose and throat, which are lined with mucosa.

Biocon Chairperson Kiran Mazumdar Shaw has commented that intra-nasal coronavirus vaccines will be far easier to deliver than intra-muscular injections, reports Live Mint.

These inoculations are administered in a single dose through the nose by spraying...

https://mfame.guru/new-nasal-vaccines-touted-to-be-game-changer-in-covid-testing/

Scientists Working on Next-Gen COVID Vaccines for Long Term Immunity

Covid-19 pandemic: the need for second-generation vaccines

According to a Pharmaceutical Technology report, there are concerns that emergency authorized vaccines may not be particularly effective at preventing Covid-19 infections in the long-term, leading to the need for improved, next-generation vaccines against this novel coronavirus.

One pair of companies working on the next phase of vaccine development are sister biotechs NantKwest and ImmunityBio.

Vaccines are the most effective way to end the Covid-19 pandemic. Credit: 
The First Generation of...

https://mfame.guru/scientists-working-on-next-gen-covid-vaccines-for-long-term-immunity/

‘Imperfect Vaccines’ To Make Early COVID Vaccines Less Impactful

According to a Reuters report, the woman in charge of procuring possible COVID-19 treatments for Britain said a fully effective vaccine might never be developed, and that any early versions that do get approved might not work at all for some people.

No Time for Complacency

There is no clinically proven vaccine against the coronavirus, though nearly 200 candidates are in development worldwide, and late-stage trial results are expected for the first of them by the end of 2020.

“However, we do not...

https://mfame.guru/imperfect-vaccines-to-make-early-covid-vaccines-less-impactful/

+ More